Development of murine experimental model for candidiasis and its application

Japanese Journal of Medical Mycology

Volumn 45, Issue 4, 2004, Pages 227-231

  Abe, Shigeru ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Chlorpromazine; Essential oil; ICR; ICR mice; Lactoferrin; White patches

Indexed keywords

CHLORPROMAZINE; ESSENTIAL OIL; HERBACEOUS AGENT; LACTOFERRIN; TEA TREE OIL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; CANDIDA ALBICANS; CANDIDIASIS; CLOVE; DRUG MECHANISM; EXPERIMENTAL MODEL; HERBAL MEDICINE; LYMPHOID TISSUE; MOUSE; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; THRUSH; TREATMENT OUTCOME;

ANIMALIA; BOVINAE; CANDIDA; CANDIDA ALBICANS; LEPTOSPERMUM; MELALEUCA ALTERNIFOLIA; MURINAE; SAMBUCUS NIGRA CANADENSIS; SYZYGIUM AROMATICUM;

EID: 10044276650     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.45.227     Document Type: Review

References (25)

1. Odds FC: Candida and Candidosis: a review and bibliography. Bailliere Tindale, London, 1988.
2. Bodey GP: Candidiasis Pathogenesis, Diagnosis and Treatment 2nd Ed. Raven Press, New York, 1993.
3. Masci JR: Complete response of severe, refractory oral Candidiasis to mouthwash containing lactoferrin and lysozyme. AIDS 14: 2403-2404, 2000.
4. Walsh TJ, Gonzalez CE, Piscitelli S, Bacher JD, Peter J, Torres R, Shetti D, Katsov V, Kligys K, Lyman CA: Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal Candidiasis. J Clin Microbiol 38: 2369-2373, 2000.
5. Martinez A, Regadera J, Jimenez E, Santos I and Gargallo-Viola D: Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral Candidiasis in immunosuppressed rats. Antimicrob Agents Chemother 45: 1008-1013, 2001.
6. Chakir J, Cote L, Coulombe C, Deslauriers N: Differential pattern of infection and immune response during experimental oral Candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol Immunol 9: 88-94, 1994.
7. Samaranayake YH, Samaranayake LP: Experimental oral Candidiasis in animal models. Clin Microbiol Rev 14: 398-429, 2001.
8. de Repentigny L, Aumont F, Ripeau JS, Fiorillo M, Kay DG, Hanna Z, Jolicoeur P: Mucosal Candidiasis in transgenic mice expressing human immunodeficiency virus type 1. J Infect Dis 185: 1103-1114, 2002.
9. Fidel PL Jr: Distinct protective host defenses against oral and vaginal Candidiasis. Med Mycol 40: 359-375, 2002.
10. Kamai Y, Kubota M, Hosokawa T, Fukuoka T, Filler SG: New model of oropharyngeal candidiasis in mice, Antimicrob Agents Chemother 45: 3195-3197, 2001.
11. Takakura N, Sato Y, Ishibashi H, Oshima H, Uchida K, Yamaguchi H, Abe S: A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol Immunol 47: 321-326, 2003.
12. Francic JK Jr: Severe oral moniliasis complicating chlorpromazine therapy. Am J Psychiatry 119: 890, 1963.
13. Abe S, Maruyama N, Ishibashi H, Hayama K, Inoue H, Oshima H, Yamaguchi H: Suppression of TNF-alpha induced neutrophil adherence response by essential oils. Mediat Inflamm 12: 323-328, 2003.
14. Abe S, Maruyama N, Hayama K, Inoue S, Oshima H, Yamaguchi H: Suppression of neutrophil recruitment in mice by geranium essential oils. Mediat Inflamm 13: 21-24, 2004.
15. Wakabayashi H, Abe S, Taraguchi S, Hayasawa H, Yamaguchi H: Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compunds. Antimicrob Agents Chemother 42: 1587-1591, 1998.
16. Okutomi T, Abe S, Tansho S, Wakabayashi H, Kawase K, Yamaguchi H: Augmented inhibition of growth of Candida albicans by neutrophils in the presence of lactoferrin. FEMS Immunol Med Mic 18: 105-112, 1997.
17. Takakura N, Wakabayashi H, Ishibashi H, Abe S, Teraguchi S, Yamaguchi H, Abe S: Oral lactoferrin treatment of experimental oral candidiasis in mice. Antimicrob Agents Chemother 47: 2619-2623, 2003.
18. Takakura N, Wakabayashi H, Ishibashi H, et al.: Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J Med Microbiol 54: 495-500, 2004.
19. Kamagata-Kiyoura Y, Abe S, Yamaguchi H, Nitta T: Detachment activity of human saliva in vitro for Candida albicans cells attached to a plastic plate. J Infect Chemother 9: 215-220, 2003.
20. Kamagata-Kiyoura Y, Abe S, Yamaguchi H, Nitta T: Reduced activity of Candida detachment activity in saliva of the elderly. J Infect Chemother 10: 59-61, 2004.
21. Kamagata-Kiyoura Y, Abe S, Yamaguchi H, Nitta T: Protective effects of human saliva on experimental murine oral candidiasis. J Infect Chemother 10: 253-255, 2004.